MEC-LV療法の奏効したVEMP後再燃非ポジキンリンパ腫の1例  [in Japanese] A case resistant to VEMP therapy benefited from MEC-LV therapy  [in Japanese]

Access this Article

Author(s)

Abstract

44才, 男性の右上顎洞, 及び右眼瞼のNHLに対しVEMP療法施行, 一旦は, 寛解を得たが約1年後, 右眼窩内に再然を認めた. そこでsalvage療法として, MTX, ET, CDDP, LVを併用したMEC-LV療法を開発施行, 完全寛解を得た. 標準的多剤併用療法に耐性を示すNHLに対し, 本療法は有用な治療法であろうと考えられる.

A 44-year-old man with NHL of the right maxillary sinus and eyelid had previously been treated with VEMPt herapy (VCR, CPM, 6MP and PDN). Nearly one year later, however, tumor involvement was detected in his right orbit. The patient was subsequently treated with the MEC-LV regimen (MTX, CDDP, ET and LV) as salvage therapy. This regimen was successful. This case suggests that MEC-LV therapy might be a useful combination of salvage chemotherapy for NHL that is resistant to VEMP therapy.

Journal

  • OTOLOGIA FUKUOKA

    OTOLOGIA FUKUOKA 37(2), 150-152, 1991

    JIBI TO RINSHO KAI

Codes

Page Top